Iloperidone for the treatment of schizophrenia Grant US-10987346-B2 United States of America 27 Apr 2021
Iloperidone metabolite for use in the treatment of psychiatric disorders Grant US-10874659-B2 United States of America 29 Dec 2020
Iloperidone for the treatment of schizophrenia Application US-10441580-B2 United States of America 15 Oct 2019
METHODS FOR THE ADMINISTRATION OF ILOPERIDONE Application EP-2331098-B1 European Patent Office 08 Aug 2018
ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS Application EP-3345603-A1 European Patent Office 11 Jul 2018
ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS Application RU-2651710-C2 Russian Federation 23 Apr 2018
AN ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS Application WO-2013138602-A1 World Intellectual Property Organisation (WIPO) 19 Sep 2013